erythrosine has been researched along with sulfasalazine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chakrabarti, KS; Choi, J; de Groot, BL; Gapsys, V; Griesinger, C; Ha, JH; Jee, JG; Kim, BR; Kim, M; Lee, D; Lee, KO; Ryu, KS | 1 |
Godsell, P; Katz, I; Wyndham, L | 1 |
Chou, CT; Tsai, CY; Wu, TH; Yu, CL | 1 |
Brandl, M; Flaten, GE; Luthman, K; Skar, M | 1 |
Bao, JQ; Bedwell, DW; Higgins, JW; Zamek-Gliszczynski, MJ | 1 |
5 other study(ies) available for erythrosine and sulfasalazine
Article | Year |
---|---|
Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IXβ Reductase B as a Novel Thrombocytopenia Therapeutic Target.
Topics: Catalytic Domain; Crystallography, X-Ray; Drug Repositioning; Enzyme Inhibitors; Humans; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Oxidoreductases Acting on CH-CH Group Donors; Protein Binding; Small Molecule Libraries; Thermodynamics; United States; United States Food and Drug Administration | 2022 |
Failure of polychromatic correction in measurement of total protein.
Topics: Adult; Aged; Blood Proteins; False Negative Reactions; Female; Fluorescein; Fluoresceins; Humans; Male; Spectrophotometry; Sulfasalazine | 1994 |
The in vitro immunomodulatory effects of sulfasalazine on human polymorphonuclear leukocytes, mononuclear cells, and cultured glomerular mesangial cells.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Cell Survival; Cells, Cultured; Dose-Response Relationship, Immunologic; Fluoresceins; Fluorescent Dyes; Glomerular Mesangium; Humans; Interleukin-4; Interleukin-8; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Neutrophils; Phagocytosis; Rats; Rats, Sprague-Dawley; Sulfasalazine | 2000 |
Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Electric Impedance; Fluoresceins; Lipid Bilayers; Membranes, Artificial; Naproxen; Permeability; Pharmaceutical Preparations; Phosphatidylcholines; Phospholipids; Spectrophotometry, Ultraviolet; Sulfasalazine; Thermodynamics | 2007 |
Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats using loperamide, paclitaxel, sulfasalazine, and carboxydichlorofluorescein pharmacokinetics.
Topics: Administration, Oral; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; Biotransformation; Brain; Fluoresceins; Gene Knockout Techniques; Genotype; Half-Life; Loperamide; Male; Metabolic Clearance Rate; Paclitaxel; Phenotype; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Sulfasalazine; Tissue Distribution | 2012 |